EC Number |
Inhibitors |
Structure |
---|
3.1.21.1 | 2-(2-(4-nitrobenzyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione |
- |
|
3.1.21.1 | 2-(2-(pyridin-2-yl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione |
- |
|
3.1.21.1 | 2-(2-ethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione |
- |
|
3.1.21.1 | 2-(3-(trifluoromethyl)phenyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine |
- |
|
3.1.21.1 | 2-(4-amidinophenyl)-6-indolecarbamidine |
significantly inhibits DNase I activity |
|
3.1.21.1 | 2-(4-nitrobenzyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine |
- |
|
3.1.21.1 | 2-(pyridin-2-yl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine |
- |
|
3.1.21.1 | 2-benzyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine |
- |
|
3.1.21.1 | 2-ethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine |
- |
|
3.1.21.1 | 2-mercaptoethanol |
inhibition, but reversal by addition of 3 mM CaCl2 |
|